Bank Of America Corp Prometheus Biosciences, Inc. Transaction History

Bank Of America Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$103.46 - $126.29 $19 Million - $23.2 Million	183,559 Added 94.4%	378,016 $40.6 Million
Q4 2022 Feb 10, 2023	BUY	$36.06 - $117.21 $4.38 Million - $14.2 Million	121,448 Added 166.35%	194,457 $21.4 Million
Q3 2022 Nov 14, 2022	BUY	$28.17 - $59.01 $1.64 Million - $3.45 Million	58,394 Added 399.55%	73,009 $4.31 Million
Q2 2022 Aug 12, 2022	BUY	$22.39 - $38.94 $108,613 - $188,897	4,851 Added 49.68%	14,615 $412,000
Q1 2022 May 16, 2022	SELL	$30.13 - $50.0 $260,534 - $432,350	-8,647 Reduced 46.97%	9,764 $368,000
Q4 2021 Feb 08, 2022	BUY	$22.28 - $39.54 $283,045 - $502,316	12,704 Added 222.6%	18,411 $728,000
Q3 2021 Nov 15, 2021	BUY	$20.89 - $26.96 $32,713 - $42,219	1,566 Added 37.82%	5,707 $136,000
Q2 2021 Sep 13, 2021	BUY	$16.8 - $29.65 $69,568 - $122,780	4,141 New	4,141 $102,000

29.6K

Ticker RXDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,904,100
Description
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.